Unknown

Dataset Information

Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB.


ABSTRACT: Although the favourable characteristics of escitalopram as being the most selective serotonin reuptake inhibitor and having an increased therapeutic efficacy via binding on an additional allosteric binding site of the serotonin transporter, its dosing regimen has not yet been optimized for its use in dogs. This study aimed to estimate the optimal dosing frequency and the required dose for achieving 80% occupancy of the serotonin transporters in the basal ganglia. The dosing frequency was investigated by determining the elimination half-life after a four day oral pre-treatment period with 0.83 mg/kg escitalopram (3 administrations/day) and a subsequent i.v. injection 0.83 mg/kg. Blood samples were taken up to 12 hours after i.v. injection and the concentration of escitalopram in plasma was

SUBMITTER: Taylor O 

PROVIDER: S-EPMC5482480 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature